🏅 FDA Orphan Designation

Onapgo

apomorphine hydrochloride

Manufacturer: MDD US Operations, LLC

Indicated for:

Hereditary late-onset Parkinson diseaseOrphanYoung-onset Parkinson disease

FDA-Approved Indications (2)

Hereditary late-onset Parkinson diseaseOrphan Designation

treatment of motor fluctuations in adults with advanced Parkinsonï¿½s disease

Young-onset Parkinson disease

ONAPGO is indicated for the treatment of motor fluctuations in adults with advanced Parkinson's disease

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE ONAPGO is indicated for the treatment of motor fluctuations in adults with advanced Parkinson's disease. ONAPGO is a dopaminergic agonist indicated for the treatment of motor fluctuations in adults with advanced Parkinson's disease. ( 1 )

💙 Support Programs

View all →

Onapgo

MDD US Operations, LLC

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.